Clinical Research Directory
Browse clinical research sites, groups, and studies.
MIBG in Aging and Neurologic Disorders
Sponsor: Mayo Clinic
Summary
The purpose of the study is to investigate the use of a special radioactive drug called 123I-MIBG and myocardial MIBG scintigraphy. This scan may be able to help determine who may have a certain kind of neurologic disorder called Lewy Body Disease. The overall purpose of this study is to correlate myocardial MIBG scintigraphy findings with clinical diagnosis. Myocardial MIBG scintigraphy imaging will be combined with other clinical, neuropsychological and neuroimaging findings to improve the prediction for underlying Lewy Body Disease.
Official title: Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease
Key Details
Gender
All
Age Range
40 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-05-08
Completion Date
2026-09
Last Updated
2025-07-10
Healthy Volunteers
Yes
Interventions
meta-iodobenzylguanidine (MIBG) (123I)
1 administration of 123I-MIBG for a single SPECT scan
123I-MIBG scintigraphy
SPECT scan involving 123I-MIBG as the ligand
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States